These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24076414)

  • 21. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients.
    Losurdo G; Castellaneta A; Rendina M; Carparelli S; Leandro G; Di Leo A
    Aliment Pharmacol Ther; 2018 Mar; 47(6):704-714. PubMed ID: 29359341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?
    Houlihan DD; Armstrong MJ; Davidov Y; Hodson J; Nightingale P; Rowe IA; Paris S; Gunson BK; Bramhall SB; Mutimer DJ; Neuberger JM; Newsome PN
    Liver Transpl; 2011 Nov; 17(11):1292-8. PubMed ID: 21761549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving aspects of liver transplantation for nonalcoholic steatohepatitis.
    Charlton M
    Curr Opin Organ Transplant; 2013 Jun; 18(3):251-8. PubMed ID: 23652610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Dong Y; Lv Q; Li S; Wu Y; Li L; Li J; Zhang F; Sun X; Tong N
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):284-295. PubMed ID: 28065744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
    van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
    Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Polyzos SA; Toulis KA; Goulis DG; Zavos C; Kountouras J
    Metabolism; 2011 Mar; 60(3):313-26. PubMed ID: 21040935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
    Afzali A; Berry K; Ioannou GN
    Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation.
    Quillin RC; Wilson GC; Sutton JM; Hanseman DJ; Paterno F; Cuffy MC; Paquette IM; Diwan TS; Woodle ES; Abbott DE; Shah SA
    Surgery; 2014 Oct; 156(4):1049-56. PubMed ID: 25239365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases.
    Kennedy C; Redden D; Gray S; Eckhoff D; Massoud O; McGuire B; Alkurdi B; Bloomer J; DuBay DA
    HPB (Oxford); 2012 Sep; 14(9):625-34. PubMed ID: 22882200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis.
    Mahfood Haddad T; Hamdeh S; Kanmanthareddy A; Alla VM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S209-S216. PubMed ID: 28017631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
    Charlton M; Kasparova P; Weston S; Lindor K; Maor-Kendler Y; Wiesner RH; Rosen CB; Batts KP
    Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist.
    Sharma S; Stine JG; Verbeek T; Bezinover D
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2616-2627. PubMed ID: 34391652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
    Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.